Thiazide nephrolithiasis
Web1 Nov 2011 · The metabolic side-effect profile of thiazide diuretics specifically used to prevent recurrent nephrolithiasis has not been well studied. 21 Only two of nine randomized controlled studies of thiazide treatment for kidney stones measured glucose and lipid levels. Clinical end points other than reduction of stones were not reported and the longest study … Web10 Dec 2024 · Nephrolithiasis is a global healthcare problem with a current lifetime risk of 18.8% in men and 9.4% in women. Given the high cost of medical treatments and surgical interventions as well as the morbidity related to symptomatic stone disease, medical prophylaxis for stone recurrence is an attractive approach. Thiazide diuretics have been …
Thiazide nephrolithiasis
Did you know?
WebDo thiazide diuretics alter the risk of recurrent nephrolithiasis in patients with a history of nephrolithiasis? LeFevre, Whitney MD; Montgomery, Lance DO; Eby, Richard MD; Kerr, … WebSummary. We have described our twenty year experience with the use of thiazides in preventing calcium stones in over 500 treated patients. New stone formation ceases completely in at least 90% of patients treated with 50 mg hydrochlorothiazide twice daily if patient compliance is good. Treatment is effective in normocalciuric as well as ...
Web1 May 2003 · Thiazide diuretics increase renal calcium resorption and cause mild hypercalcemia that should resolve when the medication is discontinued. Thiazide diuretic therapy can unmask many cases of... Web23 Jan 2024 · National Center for Biotechnology Information
Webthiazide diuretics based on where the patient received their care for stone disease. Patients were seen either in Nephrology clinic, Endocrinology clinic or other locations (Table 3). … Web1 Apr 2024 · Non-dietetic hypercalciuria may be treated by appropriate doses of thiazides (hydrochlorothiazide 25 mg twice a day or indapamide 2.5 mg once a day, eventually …
Web23 Jan 2024 · Thiazide diuretics are an FDA-approved class of drugs that inhibit reabsorption of 3% to 5% of luminal sodium in the distal convoluted tubule of the nephron. By doing so, thiazide diuretics promote natriuresis and diuresis. ... Thiazide diuretics are also indicated for use (although not FDA-approved) for nephrolithiasis, osteoporosis, and ...
WebThe effectiveness of potassium citrate as a potassium supplement was compared to that of potassium chloride in 13 patients with calcium nephrolithiasis treated with thiazide. Thiazide treatment alone reduced serum potassium, urinary calcium and citrate without affecting urinary pH. huntington grocery rewards limitsWebNational Center for Biotechnology Information mary alice treworgyWeb19 Jul 2024 · Hydrochlorothiazide (HCTZ) is a thiazide-type diuretic that has been used clinically for more than half a century. The drug has been widely used to treat hypertension globally and is relatively very safe. … mary alice tillerWebPurpose: Thiazide use to prevent recurrent calcium nephrolithiasis is supported by randomized, controlled trials. Concerns regarding adverse metabolic effects of thiazides, … huntington groupWebDo thiazide diuretics alter the risk of recurrent nephrolithiasis in patients with a history of nephrolithiasis? LeFevre, Whitney MD; Montgomery, Lance DO; Eby, Richard MD; Kerr, Jonathan MD; Dayton, Steven MD. Author Information . John Peter Smith Family Medicine Residency, Fort Worth, Texas. mary alice walker fnpWeb6 Jan 2005 · Potassium supplement of choice during thiazide treatment or in mixed calcium-uric acid nephrolithia ... Medical management of nephrolithiasis. A new, simplified approach for general practice. Am J Med Sci 313:215-219, 1997. 8. Sorensen CM, Chandhoke PS: Hyperuricosuric calcium nephrolithiasis. Endocrinol Metab Clin North Am … huntington group bloomfieldWeb14 Dec 2016 · Thiazide was administered in doses of 12.5 to 50 mg/d, either in the form of pills containing hydrochlorothiazide (HCTZ) or pills containing a combination of HCTZ 50 mg and amiloride 5 mg (n = 19). All patients also received vitamin D3 supplementation to a target serum level of at least 50 nmol/L 25-hydroxyvitamin D [25 (OH)D]. huntington group dentistry